Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Forescout Medical Device Security, a dedicated healthcare solution, is part of Forescout Continuum. The CyberMDX Healthcare Security suite was formerly known as this solution. It provides continuous, real-time visibility and discovery of all medical devices connected to your clinical network. The solution then evaluates the risk of each device by taking into account known exposures, attack potential, and operational criticality. Continuous, real-time discovery and analysis of your connected medical devices, clinical network, and devices behind firewalls or serial gateways. Clear and concise risk assessment for each connected medical device, based on known exposures and attack potential. Also includes operational criticality using AI and rule-based attack detection. Each connected medical device has its own security policy and access. Smart isolation blocks device access to prevent unauthorized nodes.
Description
Introducing the only comprehensive IoT security solution in the market, which provides visibility, prevention, and enforcement for every Internet of Things (IoT) and operational technology (OT) device. This innovative approach not only safeguards your IoT investments but also eliminates potential risks associated with them. In today's digital landscape, securing IoT devices is non-negotiable, as unmanaged IoT and OT devices comprise approximately 30% of many enterprises. These unmanaged devices can be challenging to secure and often remain vulnerable to threats that go unnoticed. Fortunately, when it comes to IoT security, options are available. Palo Alto Networks empowers security teams to swiftly identify and safeguard all unmanaged IoT and OT devices through a machine-learning-based, signature-less methodology. Building on the advanced Zingbox technology, we have developed the industry's first turnkey IoT security solution that encompasses visibility, prevention, risk assessment, and enforcement, integrated seamlessly with our machine learning-powered Next-Generation Firewall. Moreover, there is no need to invest in new network infrastructure or alter existing operational workflows, making it easier than ever to enhance your security posture. With such a robust solution, organizations can confidently navigate the complexities of IoT security.
API Access
Has API
No
API Access
Has API
No
Integrations
Check Point Exposure Management
No
Check Point IPS
Yes
Check Point Infinity
Yes
VirtualArmour
No
Integrations
Check Point Exposure Management
Yes
Check Point IPS
No
Check Point Infinity
No
VirtualArmour
Yes
Pricing Details
No price information available.
Free Trial
Yes
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Forescout Technologies
Founded
2000
Country
United States
Website
www.forescout.com/solutions/medical-device-security/
Vendor Details
Company Name
Palo Alto Networks
Founded
2005
Country
United States
Website
www.paloaltonetworks.com/network-security/iot-security
Product Features
Cybersecurity
AI / Machine Learning
Yes
Behavioral Analytics
Yes
Endpoint Management
No
IOC Verification
Yes
Incident Management
No
Tokenization
No
Vulnerability Scanning
Yes
Whitelisting / Blacklisting
No
Product Features
IoT
Application Development
No
Big Data Analytics
No
Configuration Management
No
Connectivity Management
No
Data Collection
No
Data Management
No
Device Management
No
Performance Management
No
Prototyping
No
Visualization
No